Country: South Africa
Language: English
Source: South African Health Products Regulatory Authority (SAHPRA)
Aspen-p
AUTRIN* Capsules SCHEDULING STATUS: Unscheduled PROPRIETARY NAME (and dosage form): AUTRIN* Capsules COMPOSITION: Each AUTRIN* haematinic capsule contains: Vitamin B 12 (15 micrograms) with Intrinsic Factor Concentrate 1.5 N.F. Units (Oral) Ferrous Fumarate 350 mg (Elemental iron 115 mg) Ascorbic Acid ( Vitamin C ) 150 mg Folic Acid 2 mg PHARMACOLOGICAL CLASSIFICATION: A 8.3 Erythropoietics (Haematinics) PHARMACOLOGICAL ACTION: AUTRIN* is used for the treatment of anaemias as indicated below. It contains the common substances used in the prevention and treatment of anaemic conditions. INDICATIONS: Indicated for the treatment and maintenance of common anaemias, including iron-deficient anaemias, megaloblastic anaemias of pregnancy, pellagra and those of nutritional origin. All of the other means that are recognised as suited to the treatment of these anaemias should also be employed. If cases prove resistant to this form of therapy, further exploration of the aetiology and additional therapeutic measures should be instituted. CONTRA-INDICATIONS: Hypersensitivity to any of the ingredients. Symptoms of iron intolerance. WARNINGS: See "Side-effects and Special Precautions" below. Prolonged administration in excess of the recommended dose as prescribed by the physician (one capsule per day) may result in iron overload. Iron overloading and toxicity may occur in patients receiving both oral and parenteral administration of iron. DOSAGE AND DIRECTIONS FOR USE: One capsule daily with or after meals will treat and maintain the average uncomplicated case of anaemia. SIDE-EFFECTS AND SPECIAL PRECAUTIONS: Side-effects: Some patients affected with pernicious anaemia may not respond to orally administered Vitamin B 12 with Intrinsic Factor Concentrate and there is no Read the complete document